Meyer JM - Search Results

1

Converting oral to long-acting injectable antipsychotics: a guide for the perplexed.

Meyer JM. Meyer JM. CNS Spectr. 2017 Dec;22(S1):14-28. doi: 10.1017/S1092852917000840. CNS Spectr. 2017. PMID: 29350127 Review.

2

Drug-drug interactions with antipsychotics.

Meyer J. Meyer J. CNS Spectr. 2007 Dec;12(12 Suppl 21):6-9. doi: 10.1017/s1092852900015947. CNS Spectr. 2007. PMID: 18389925 Review. No abstract available.

3

“Meta-guidelines” for the management of patients with schizophrenia.

Stahl SM, Morrissette DA, Citrome L, Saklad SR, Cummings MA, Meyer JM, O'Day JA, Dardashti LJ, Warburton KD. Stahl SM, et al. Among authors: meyer jm. CNS Spectr. 2013 Jun;18(3):150-162. doi: 10.1017/S109285291300014X. CNS Spectr. 2013. PMID: 23591126 Review.

4

Understanding depot antipsychotics: an illustrated guide to kinetics.

Meyer JM. Meyer JM. CNS Spectr. 2013 Dec;18 Suppl 1:58-67; quiz 68. doi: 10.1017/S1092852913000783. CNS Spectr. 2013. PMID: 24345710

5

A rational approach to employing high plasma levels of antipsychotics for violence associated with schizophrenia: case vignettes.

Meyer JM. Meyer JM. CNS Spectr. 2014 Oct;19(5):432-8. doi: 10.1017/S1092852914000236. Epub 2014 May 27. CNS Spectr. 2014. PMID: 24865765 Review.

6

Augmentation of phenelzine with aripiprazole and quetiapine in a treatment-resistant patient with psychotic unipolar depression: case report and literature review.

Meyer JM, Cummings MA, Proctor G. Meyer JM, et al. CNS Spectr. 2017 Oct;22(5):391-396. doi: 10.1017/S1092852916000821. Epub 2016 Dec 22. CNS Spectr. 2017. PMID: 28004621 Review.

7

Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus.

Black KJ, Nasrallah H, Isaacson S, Stacy M, Pahwa R, Adler CH, Alva G, Cooney JW, Kremens D, Menza MA, Meyer JM, Patkar AA, Simuni T, Morrissette DA, Stahl SM. Black KJ, et al. Among authors: meyer jm. CNS Spectr. 2018 Dec;23(6):402-413. doi: 10.1017/S1092852918001359. CNS Spectr. 2018. PMID: 30588905 Review.

8

Size matters: the importance of particle size in a newly developed injectable formulation for the treatment of schizophrenia.

Jain R, Meyer J, Wehr A, Rege B, von Moltke L, Weiden PJ. Jain R, et al. CNS Spectr. 2020 Jun;25(3):323-330. doi: 10.1017/S1092852919000816. Epub 2019 May 21. CNS Spectr. 2020. PMID: 31111801 Review.

9

Monitoring and improving antipsychotic adherence in outpatient forensic diversion programs.

Meyer JM. Meyer JM. CNS Spectr. 2020 Apr;25(2):136-144. doi: 10.1017/S1092852919000865. Epub 2019 May 23. CNS Spectr. 2020. PMID: 31120002 Review.

10

The Cal-DSH diversion guidelines.

Cummings MA, Scott C, Arguello JC, Arias AW, Breth AM, Delgado D, Harvey PD, Meyer JM, O'Day J, Pollock M, Proctor G, Rector T, Rose B, Schwartz E, Thordarson H, Warburton K, Stahl SM. Cummings MA, et al. Among authors: meyer jm. CNS Spectr. 2020 Oct;25(5):701-713. doi: 10.1017/S1092852920001819. CNS Spectr. 2020. PMID: 33111661 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

584 results

Search Page